PRX-111

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePRX-111
Drug Alias NameFSH variants (Protalix Biotherapeutics/Compugen)follicle stimulating hormone variants (Protalix Biotherapeutics/Compugen)PRX-111
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtalix Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtalix Biotherapeutics IncCompugen Ltd
Active IndicationsN/A
Inactive IndicationsInfertility, Female

Other Information

ATC CodeN/A
Related LinksN/A